1. Introduction {#sec1}
===============

Most adults have the experience of low back pain (LBP) in their lives \[[@B1], [@B2]\]. Low back pain is one of the most common complaints when patients visit the emergency department (ED) \[[@B3], [@B4]\]. Most cases of acute LBP are not related to any specific disease \[[@B5]--[@B7]\]. After checking the patients and excluding any life-threatening conditions or severe neurological deficits, sometimes the pain has still not been eased. Patients must be kept in the ED for further observation. The prolonged hospital stay due to poor pain control is a potential factor that can cause the overcrowding of the ED \[[@B8]\].

Pain has been regarded as the fifth vital sign (temperature, heart rate, blood pressure, and respiratory rate) recently \[[@B9]\], and every patient has the right to receive adequate pain management. Pain relief is an important work in the ED and there are many medications for LBP with each medication having both benefits and side effects \[[@B10]--[@B13]\].

Acupuncture is one of the oldest and most popular complementary alternative medicines in the world and it has been widely utilized for pain, including low back pain, osteoarthritis, headache, and cancer \[[@B14]--[@B19]\]. We found that there are many studies assessing the effectiveness of acupuncture for chronic LBP but few for acute LBP \[[@B15], [@B20]\].

In light of the aforementioned observation, this study focused on evaluating the efficacy and safety of acupuncture in patients with acute LBP through outpatient care in the ED.

2. Materials and Methods {#sec2}
========================

2.1. Population {#sec2.1}
---------------

A clinical pilot cohort study was conducted. Patients were recruited from the emergency department (ED) of Changhua Christian Hospital (a medical center in Taiwan) with a target sample size of 60 subjects. Participants were divided into either the experimental group or control group based on their willingness to accept acupuncture treatment. All candidates received a standardized interview process. And the purpose, procedures, potential risks, and benefits of the study were explained thoroughly to the candidates. Participants had the right to withdraw from the study at any time without any consequence. All participants\' written consents were obtained. The trial was conducted from March to December, 2014. The clinical trial protocol was approved by the Institute Review Board (IRB) of Changhua Christian Hospital (CCH IRB number 140214).

2.2. Inclusion Criteria {#sec2.2}
-----------------------

Participants meeting all of the following criteria will be included:age 20 to 90 years, either gender;visit and stay in emergency department;the chief complaint being acute low back pain;diagnosis with International Classification of Diseases 9th revision (ICD-9) code 724.2 Lumbago.

2.3. Exclusion Criteria {#sec2.3}
-----------------------

Participants meeting one or more of the following criteria were excluded:serious comorbid conditions (e.g., life-threatening condition or severe neurological defects);patients who cannot communicate reliably with the investigator or who are not likely to obey the instructions of the trial;pregnancy status.

2.4. Baseline Assessment {#sec2.4}
------------------------

### 2.4.1. The Oswestry Disability Index (ODI) {#sec2.4.1}

This questionnaire (also known as Oswestry Low Back Pain Disability Questionnaire) was designed to measure a patient\'s functional disability resulting from spinal pain \[[@B21]\].

2.5. Interventions {#sec2.5}
------------------

Participants were divided into experimental and control groups based on their willingness to accept acupuncture treatment. The experimental group received a series of fixed points of acupuncture: Bilateral Hegu (LI4), Shousanli (LI10), Zusanli (ST36), Yanlingquan (GB34), and Taichong (LR3) \[[@B22]\]. Needles were correctly inserted and manually stimulated until the "De Qi" sensation was elicited. The needles stayed in place for 15 minutes. The control group received sham acupuncture by pasting seed-patches next to the same location as correct acupoints of experimental group; see [Figure 2](#fig2){ref-type="fig"} \[[@B22]\].

2.6. Evaluations {#sec2.6}
----------------

The primary outcome evaluation was the visual analog scale (VAS) for pain. It is graded from 0 (no pain) to 10 (worst possible pain) and has proven its usefulness and clinical validity for the evaluation of pain \[[@B23]\]. Patients were evaluated at three timepoints in this study: before intervention (VAS-1), after intervention (VAS-2), 3 days after the intervention (VAS-3).

The secondary outcomes were heart rate variability (HRV) and adverse events. HRV was measured 2 times in this study: before the intervention and after the intervention. Many studies have shown a relation between HRV and pain \[[@B24], [@B25]\]. We tried to further identify the correlation between the intensity of pain and HRV \[[@B26], [@B27]\]. An additional secondary outcome was participants reporting any adverse events they experience, including discomfort, bruising at the sites of needle insertion, nausea, or feeling faint during or after treatment.

2.7. Data Analysis {#sec2.7}
------------------

First, the experimental group and control group were analyzed for comparability according to the baseline characteristics, including gender, age, body mass index (BMI), blood pressure (systole and diastole), heart rate (HR), and ODI. Chi-square test and Mann-Whitney *U* test were used to assess categorical variables. Second, in order to analyse the outcome of this study including VAS and HRV, we used Wilcoxon Signed Ranks Test and Mann-Whitney *U* test because of the sample size. All tests were conducted using SPSS (V.18.0).

3. Results {#sec3}
==========

The flowchart of this study is presented in [Figure 1](#fig1){ref-type="fig"}.

*Participant Recruitment*. All study participants, from the emergency department (ED), were evaluated by emergency medicine specialists to exclude serious comorbid conditions and severe neurological defects, such as infection, cauda equina syndrome, and aneurysm. Sixty participants (21--89 years old, 20 men and 40 women) were recruited into the study and divided into experimental group (*n* = 46) and control group (*n* = 14). The VAS was conducted to evaluate the maintenance of the pain relieving effect by phone interview 3 days after treatment. There was 1 participant lost to follow-up in the experimental group at the 3 days after intervention timepoint.

*Baseline Characteristics*. Tables [1](#tab1){ref-type="table"}(a) and [1](#tab1){ref-type="table"}(b) show baseline participant characteristics, including gender, age, BMI, blood pressure, heart rate, and Oswestry Disability Index. The two groups were homogeneous while no significant difference was shown at baseline assessment.

*VAS*. Comparison of VAS-1 (before intervention) and VAS-2 (after intervention) indicated that there was significant difference in the experimental group (*P* \< 0.001) but not in control group (*P* = 0.109). Comparison of VAS-1 and VAS-3 (3 days after intervention) found significant differences in both experimental group (*P* \< 0.001) and control group (*P* = 0.011) (see [Table 2](#tab2){ref-type="table"}).

In addition, comparison of ΔVAS1-VAS2 (changes of VAS-1 and VAS-2) between two groups also showed a significant difference (*P* \< 0.001). No significant difference was observed in ΔVAS1-VAS3 (changes of VAS-1 and VAS-3) (*P* = 0.370) and ΔVAS2-VAS3 (changes of VAS-2 and VAS-3) (*P* = 0.181) (see [Table 3](#tab3){ref-type="table"}).

Furthermore, when we do the gamma regression model with GEE method on VAS, the results also indicate a significant change after treatment in the experimental group (*P* \< 0.001) but not in the control group. The VAS reduced significantly in all patients after 3 days (*P* = 0.031) (see [Table 5](#tab5){ref-type="table"}).

*HRV*. [Table 4](#tab4){ref-type="table"} shows the comparison of all parameters of HRV before and after intervention in experimental group and control group. No significant change was observed in HRV, HF%, LF%, LF/HF, VLF, LF RMSSD, and PNN50 in both groups in this study.

*Adverse Events*. No side effects were reported in this study. No patients reported bleeding, nausea, vomiting, feeling faint, or any other complication during or after intervention.

4. Discussion {#sec4}
=============

This study was designed to demonstrate that acupuncture can benefit patients with acute LBP. Instead of recruiting participants from acupuncture outpatients, we cooperated with emergency medicine specialists in order to make the first contact with patients with acute LBP. Clinically we found that most patients with acute LBP would not be able to maintain the face-down posture during the treatment time. Therefore, all the acupoints we chose in this study were at the limbs and based on traditional Chinese medical meridian system, so patients could keep a relatively comfortable lying down position.

In the results of this study, the significant difference between VAS-1 and VAS-2 in the experimental group might prove the efficacy of acupuncture while no statistical variation was shown in control group. Another significant variation was shown in the change of VAS-1 and VAS-2 (ΔVAS1-VAS2) between two groups. It also indicated that acupuncture intervention might reduce the pain intensity. The other significant variation was between VAS-1 and VAS-3 in both groups. And it was considered as acute LBP could be mitigated through appropriate treatment without immediate recurrence \[[@B28]\].

HRV measures the balance of autonomic nervous system which reflects physiological, hormonal, and emotional balance within our body \[[@B29]\]. Many studies have proved that there are statistical differences of HRV between healthy people and patients in pain \[[@B24], [@B30]\]. But the correlation between HRV and pain intensity has not been clearly demonstrated \[[@B24], [@B31]\]. In our study, no significant difference was shown in both experimental and control group after intervention. We assume that patients might feel much less pain after 15 minutes of acupuncture (mean 6.64 ± 1.87 to 3.98 ± 1.74) but have not yet fully recovered to pain-free state.

We used the adverse event record to assess the safety. No complication was reported showing that acupuncture could be a safe treatment in patients with acute LBP. However, our study has several limitations. One limitation concerned the different number of participants between two groups. Acupuncture is a common and popular medical service in the Chinese society. Patients are usually willing to accept it. It resulted in the fact that less participants were recruited into control group when our strategy was to divide participants into two groups based on their willingness to accept acupuncture.

Another limitation was that this study was not designed as randomized blind. Considering that acupuncture is well-known in the Chinese society, it is difficult to do blinded study about acupuncture. In order to minimize the bias from this, we used seed-patches as sham acupuncture. Seed-patches are often used in auricular acupuncture. Auricular acupuncture is another well-known Chinese medical service. We tried to convince participants in control group that they were also receiving another effective treatment by pasting the seed-patches near the correct acupoints \[[@B32], [@B33]\]. Still, biases introduced by this unblinded approach cannot be ruled out.

A larger sample size in future studies is indispensable to provide well-defined types of acute low back pain for our evidence-based practice.

5. Conclusion {#sec5}
=============

We conclude that acupuncture could provide immediate effect in reducing pain of acute low back pain significantly. The results from this study provide clinical evidence on the efficacy and safety of acupuncture to treat acute low back pain in the emergency department. Nevertheless, further larger studies are needed to replicate the findings of this study.
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###### 

\(a\) Distribution of participants\' gender. (b) Baseline of participant characteristics.

            Control   Acupuncture   *P* value          
  --------- --------- ------------- ----------- ------ -------
  Gender    14                      45                 0.942
   Female   7         50.0          23          51.1   
   Male     7         50.0          22          48.9   

*P* value by Chi-square test.

  ----------------------------------------------------------------------------------------------------------
                        Control (*n* = 14)   Acupuncture (*n* = 45)   *P* value\                     
  --------------------- -------------------- ------------------------ ------------ ----- ----- ----- -------
  Age                   65                   52                       79           56    46    75    0.423

  BMI                   26                   23                       28           24    22    27    0.454

  SYS                   134                  119                      137          122   117   138   0.741

  DIA                   76                   73                       78           74    71    79    0.533

  HR                    81                   77                       91           75    67    88    0.303

  Oswestry                                                                                            

   (1) Pain intensity   3                    2                        4            3     3     4     0.861

   (2) Personal care    2                    1                        5            3     2     4     0.930

   (3) Lifting          5                    5                        5            4     3     5     0.024

   (4) Walking          4                    3                        5            4     3     5     0.767

   (5) Sitting          4                    2                        5            4     3     5     0.745

   (6) Standing         4                    3                        5            4     1     4     0.099

   (7) Sleeping         2                    1                        4            3     1     4     0.648

   (8) Sex life         4                    4                        4            4     2     4     0.448

   (9) Social life      4                    3                        5            4     3     5     0.205

   (10) Traveling       5                    3                        5            5     3     5     0.853
  ----------------------------------------------------------------------------------------------------------

*P* value by Mann-Whitney *U* test.

Q~1~: Percentile 25.

Q~3~: Percentile 75.

BMI, body mass index; SYS, systolic pressure; DIA, diastolic pressure; HR, heart rate.

###### 

Comparison between groups of VAS before, after, and 3 days after intervention.

          Control (*n* = 14)   Acupuncture (*n* = 45)   *P* value^b^                                         
  ------- -------------------- ------------------------ -------------- ---------- ----- --- --- ------------ -------
  VAS-1   5.5                  4                        7                         7.0   5   8                0.059
  VAS-2   4.5                  4                        6              0.109      4.0   2   5   \<0.001^∗^   0.161
  VAS-3   3.0                  0                        4              0.011^∗^   3.0   1   6   \<0.001^∗^   0.465

*P* value^a^ by Wilcoxon Signed Ranks Test (take VAS1 as reference) (intergroup).

*P* value^b^ by Mann-Whitney *U* test (between groups).

Q~1~: Percentile 25.

Q~3~: Percentile 75.

VAS-1, VAS before intervention; VAS-2, VAS after intervention; VAS-3, VAS of 3 days after intervention.

^\*^Statistically significant difference (*P* \< 0.05).

###### 

Changes in VAS between control group and acupuncture group.

               Control (*n* = 14)   Acupuncture (*n* = 45)   *P* value                    
  ------------ -------------------- ------------------------ ----------- ------ ---- ---- ------------
  ΔVAS2-VAS1   0.0                  0                        0           −2.0   −4   −1   \<0.001^∗^
  ΔVAS3-VAS1   −1.5                 −3                       0           −4.0   −5   −1   0.370
  ΔVAS3-VAS2   −1.5                 −3                       0           −1.0   −3   2    0.181

*P* value by Mann-Whitney *U* test.

Q~1~: Percentile 25.

Q~3~: Percentile 75.

^\*^Statistically significant difference (*P* \< 0.05).

ΔVAS2-VAS1, changes of VAS-2 and VAS-1; ΔVAS3-VAS1, changes of VAS-3 and VAS-1; ΔVAS3-VAS2, changes of VAS-3 and VAS-2.

###### 

Comparison of parameters of heart rate variability (HRV) before and after intervention in two groups.

  ----------------------------------------------------------------------------------------------
  Group                           Before   After    *P* value                            
  ---------------------- -------- -------- -------- ----------- ------- -------- ------- -------
  Control\               HRV      39.0     33.0     49.0        31.0    26.0     45.0    0.311
  (*n* = 14)                                                                             

  HF%                    50.0     38.0     58.0     53.0        48.0    76.0     0.421   

  LF%                    50.0     42.0     62.0     47.0        24.0    52.0     0.421   

  LF/HF                  1.0      0.7      1.6      0.9         0.3     1.1      0.133   

  VLF                    976.0    567.0    1436.0   628.0       501.0   1098.0   0.463   

  Number of irreg. hb.   8.0      0.0      48.0     2.0         0.0     13.0     0.229   

  LF                     305.0    92.0     509.0    154.0       54.0    199.0    0.552   

  HF                     258.0    196.0    323.0    224.0       133.0   428.0    0.916   

  Total power            1521.0   1089.0   2401.0   961.0       676.0   2025.0   0.311   

  Variance               1521.0   1089.0   2401.0   961.0       676.0   2025.0   0.311   

  RMSSD                  45.0     29.0     52.0     41.0        22.0    54.0     0.674   

  PNN50                  13.0     8.0      30.0     20.0        1.0     30.0     0.753   

                                                                                         

  Acupuncture\           HRV      40.0     25.0     83.0        34.0    24.0     58.0    0.273
  (*n* = 45)                                                                             

  HF%                    45.0     32.0     61.0     46.0        32.0    60.0     0.694   

  LF%                    55.0     39.0     68.0     53.0        39.0    68.0     0.905   

  LF/HF                  1.2      0.6      2.1      1.1         0.7     2.1      0.923   

  VLF                    891.0    382.0    4272.0   732.0       423.0   2274.0   0.561   

  Number of irreg. hb.   11.0     0.0      49.0     6.5         0.0     22.0     0.158   

  LF                     204.0    77.0     1095.0   185.0       53.0    667.0    0.891   

  HF                     208.0    68.0     932.0    141.5       71.0    503.0    0.446   

  Total power            1600.0   625.0    6889.0   1157.0      576.0   3364.0   0.401   

  Variance               1600.0   625.0    6889.0   1157.0      576.0   3364.0   0.401   

  RMSSD                  34.0     22.0     75.0     32.0        22.0    59.0     0.573   

  PNN50                  11.0     1.0      45.0     8.5         2.0     31.0     0.353   
  ----------------------------------------------------------------------------------------------

*P* value by Wilcoxon Signed Ranks Test.

Q~1~: Percentile 25.

Q~3~: Percentile 75.

HF, high frequency; LF, low frequency; VLF, very low frequency; Number of irreg. hb., number of irregular heart beats; RMSSD, root mean square successive difference; PNN50, NN50 count divided by the total number of all NN intervals.

###### 

Results of gamma regression model with GEE method on VAS.

  Predictor             Coefficient   SE      Mean ratio   95% C.I.        *P* value
  --------------------- ------------- ------- ------------ --------------- ------------
  (Intercept)           1.701         0.368   5.478        2.665--11.259   \<0.001^∗^
  Age                   0.001         0.002   1.001        0.997--1.005    0.637
  BMI                   −0.001        0.012   0.999        0.977--1.022    0.920
  Gender                                                                    
   Male                 0.008         0.096   1.008        0.835--1.215    0.936
   Female               0.000                 1.000                         
  Group                                                                     
   Acupuncture          0.156         0.098   1.169        0.964--1.417    0.113
   Control              0.000                 1.000                         
  Time                                                                      
   3                    −0.377        0.175   0.686        0.487--0.966    0.031^∗^
   2                    −0.132        0.077   0.876        0.753--1.019    0.086
   1                    0.000                 1.000                         
  Interaction                                                               
   Acupuncture Time 3   0.021         0.196   1.021        0.695--1.499    0.916
   Acupuncture Time 2   −0.380        0.092   0.684        0.571--0.819    \<0.001^∗^
   Acupuncture Time 1   0.000                 1.000                         
   Control Time 3       0.000                 1.000                         
   Control Time 2       0.000                 1.000                         
   Control Time 1       0.000                 1.000                         

^\*^Statistically significant difference (*P* \< 0.05).
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